Cyclosporine therapy is highly effective in the treatment of psoriasis. To minimize side effects, the lowest effective dosage for maintenance therapy should be sought.
We selected 61 patients who had achieved clearing or near-clearing of psoriasis during an induction phase of cyclosporine therapy. We then randomly assigned them in a double-blind fashion to receive one of two dosages of cyclosporine (1.5 or 3 mg/kg per day) or placebo for maintenance treatment. For each patient, the time to relapse was the time from the start of maintenance therapy until the patient showed a two-point worsening of psoriasis on a seven-point scale, up to a maximum of 4 months, when the study ended.
Sixty patients completed the maintenance study. The mean time to relapse was significantly longer in the 3-mg/kg group (12± 1 weeks) than in the 1.5-mg/kg group (9±1 weeks; P=.04) and the placebo group (7± 1
Ellis CN, Fradin MS, Hamilton TA, Voorhees JJ. Duration of Remission During Maintenance Cyclosporine Therapy for PsoriasisRelationship to Maintenance Dose and Degree of Improvement During Initial Therapy. Arch Dermatol. 1995;131(7):791-795. doi:10.1001/archderm.1995.01690190043008